Hypertension and the cardiometabolic syndrome (Q36231658)

12 August 2017

1 reference

title

Hypertension and the cardiometabolic syndrome (English)

1 reference

12 August 2017

Camila Manrique

1 reference

12 August 2017

Guido Lastra

series ordinal

1 reference

12 August 2017

Adam Whaley-Connell

series ordinal

1 reference

12 August 2017

James R Sowers

series ordinal

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Journal of Clinical Hypertension

12 August 2017

published in

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

page(s)

471-476

1 reference

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Treatment of cardiovascular and renal risk factors in the diabetic hypertensive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Obesity as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Fasting insulin in relation to subsequent blood pressure changes and hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Insulin and blood pressure among healthy children. Cardiovascular risk in young Finns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Insulin secretion, sensitivity, and metabolic profile of young healthy offspring of hypertensive parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Hypertension, insulin resistance, and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

21 January 2018

Hypertension and obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Endothelial Dysfunction: Does It Matter? Is It Reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Hypertension, angiotensin II, and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

21 January 2018

The Epidemic of Obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04617.X

10.1111/J.1524-6175.2005.04617.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference